MedPath

Imperial College London

Imperial College London logo
🇧🇪Belgium
Ownership
Private
Established
1907-07-08
Employees
5K
Market Cap
-
Website
http://www.imperial.ac.uk

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Completed
Conditions
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriatic Arthritis
Interventions
Drug: anti-TNF therapy (etanercept or adalimumab)
First Posted Date
2010-02-02
Last Posted Date
2020-01-18
Lead Sponsor
Imperial College London
Target Recruit Count
48
Registration Number
NCT01060098
Locations
🇬🇧

Kennedy Institute Clinical Trials Unit, 4Wl, Charing Cross Hospital, London, United Kingdom

High Frequency Chest Wall Oscillation and Cystic Fibrosis

Phase 3
Completed
Conditions
Cystic Fibrosis
Interventions
Device: High Frequency Chest Wall Oscillation (HFCWO)
Other: Usual airway clearance
First Posted Date
2010-01-27
Last Posted Date
2016-11-11
Lead Sponsor
Imperial College London
Target Recruit Count
56
Registration Number
NCT01057524
Locations
🇬🇧

Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

Phase 3
Completed
Conditions
Cardiovascular Diseases
Interventions
Drug: Usual cardiovascular medications
First Posted Date
2010-01-27
Last Posted Date
2012-11-27
Lead Sponsor
Imperial College London
Target Recruit Count
2004
Registration Number
NCT01057537
Locations
🇮🇳

George Institute for International Health - India, Hyderabad, India

🇮🇳

Public Health Foundation of India, New Dehli, India

🇮🇪

Royal College of Surgeons in Ireland Research Institute, Dublin, Ireland

and more 4 locations

PPrime: Parents Views on Diagnosis and Information-giving in Neonatal Care (Pilot Study)

Completed
Conditions
Parents of Preterm Infants Born Before 33 Weeks Gestation
First Posted Date
2010-01-25
Last Posted Date
2015-06-03
Lead Sponsor
Imperial College London
Target Recruit Count
20
Registration Number
NCT01055548
Locations
🇬🇧

Hammersmith Hospital, London, United Kingdom

A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects

Phase 1
Completed
Conditions
Obesity
Interventions
Drug: Placebo
First Posted Date
2010-01-20
Last Posted Date
2021-02-12
Lead Sponsor
Imperial College London
Target Recruit Count
13
Registration Number
NCT01052493
Locations
🇬🇧

Sir John McMichael Centre for Clinical Studies, Imperial College Healthcare NHS Trust, London, United Kingdom

Chemoreflex Gain on Exercise

Phase 1
Conditions
Exertional Periodic Breathing
First Posted Date
2010-01-15
Last Posted Date
2010-04-19
Lead Sponsor
Imperial College London
Target Recruit Count
20
Registration Number
NCT01050179
Locations
🇬🇧

St Mary's Hospital, Paddington, London, United Kingdom

The Cyclocapnic Method for Measurement of Chemosensitivity

Phase 1
Conditions
Periodic Breathing
Heart Failure
First Posted Date
2010-01-14
Last Posted Date
2010-01-14
Lead Sponsor
Imperial College London
Target Recruit Count
45
Registration Number
NCT01049256
Locations
🇬🇧

St Mary's Hospital, London, United Kingdom

ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm Infants

Conditions
Cerebral Palsy
First Posted Date
2010-01-14
Last Posted Date
2015-06-03
Lead Sponsor
Imperial College London
Target Recruit Count
625
Registration Number
NCT01049594
Locations
🇬🇧

Northwick Park Hospital, London, United Kingdom

🇬🇧

Barnet General Hospital, London, United Kingdom

🇬🇧

Kingston Hospital NHS Trust, London, United Kingdom

and more 10 locations

Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

Phase 4
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2010-01-08
Last Posted Date
2010-04-13
Lead Sponsor
Imperial College London
Target Recruit Count
240
Registration Number
NCT01044719
Locations
🇬🇧

Department of Cystic Fibrosis, Royal Brompton Hospital, London, United Kingdom

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

Completed
Conditions
Secondary Progressive Multiple Sclerosis
Relapsing-remitting Multiple Sclerosis
First Posted Date
2010-01-08
Last Posted Date
2021-03-08
Lead Sponsor
Imperial College London
Target Recruit Count
200
Registration Number
NCT01044576
Locations
🇬🇧

Imperial College NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath